Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Acute Market Reports | PRODUCT CODE: 1234372

Cover Image

PUBLISHER: Acute Market Reports | PRODUCT CODE: 1234372

Postpartum Hemorrhage (PPH) Treatment Devices Market - Growth, Future Prospects and Competitive Analysis, 2023 - 2031

PUBLISHED:
PAGES: 120 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 4500
PDF (Multi User License)
USD 6500
PDF (Enterprise License)
USD 9000

Add to Cart

Postpartum Hemorrhage (PPH) Treatment Devices Market Expected to Grow at 4.5% by 2031. The key factor that drives the postpartum hemorrhage devices market growth includes increase in complications in pregnancy, including large size baby, inverted uterus, and multiple pregnancies. Moreover, rise in PPH risk factors, such as uterine atony and trauma; growth in anemia cases in pregnant women; and surge in awareness regarding PPH risk factors boost the growth during postpartum hemorrhage devices market forecast.

Despite being a preventable and treatable condition, postpartum hemorrhage (PPH) the leading direct cause of maternal deaths worldwide. However, women in low respurce stings may not have desired access to appropriate care. This condition causes approximately 25% of the total maternal deaths. PPH is defined as excessive vaginal bleeding and occurs in over 10% of the total births and is linked with 1% case fatality rate. Active management of third stage labor can prevent up to 60% PPH cases, it still has devastating effect in low-income countries. Currently PPH causes approximately 34% and 31% of maternal deaths in Africa and Asia, whereas 31% in Caribbean and Latin America. A majority of primary PPH cases are caused byb uterine atony and result in prolonged labor, and preclampsia.

Among the available products for treating PPH, uterine balloon tamponades segment currently experiences the highest demand. Better effectiveness, ease of use and wide availability are the key factors contributing to the dominance of this segment. Additionally, the demand for uniject prefilled injection systems is expected to be the highest during the forecast period. Ease of application, greater support from governments and convenient pricing mainly support the rapid growth of this segment. On the other hand, non-pneumatic anti-shock garment (NASG) segment will undergo satisfactorily fast market growth during the forecast period.

North America currently holds over 30% of the global share thereby dominating the market. Higher hospital birth rates, greater awareness among patients and healthcare providers and favorable government policies fuel the lead of North America market. The demand for PPH treatment devices will be the highest in Asia Pacific due to greater population pool and and swift evolution of healthare infrastructure. Additionally, increase in the number of welfare initiatives undertaken by governments for augmenting hospital births and preventing maternal deaths will also assist in boosting the demand for novel PPH treatment devices during the forecast period.

Some key players identified for Postpartum Hemorrhage Treatment Devices market include:

C. R. Bard, Inc., Cook Medical, Inc., Becton Dickinson and Company, Teleflex Incorporated, Bactiguard AB, Utah Medical Products Inc., 3rd Stone Design, Bactiguard AB, Becton, Dickinson and Company Clinical Innovations, LLC., Cook, Obstetrx, Organon, Path, Teleflex Incorporated, and Utah Medical Products, Inc and others.

Historical & Forecast Period

This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2023 to 2031.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Postpartum Hemorrhage (PPH) Treatment Devices market are as follows:

Research and development budgets of manufacturers and government spending

Revenues of key companies in the market segment

Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Postpartum Hemorrhage (PPH) Treatment Devices market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Product

Uterine balloon tamponade

Bakri balloon tamponade

Condom catheter

Foley catheter

BT-Cath balloon

Uniject prefilled injection system

Non-pneumatic anti-shock garment (NASG)

Region Segment (2021-2031; US$ Million)

North America

U.S.

Canada

Rest of North America

UK and European Union

UK

Germany

Spain

Italy

France

Rest of Europe

Asia Pacific

China

Japan

India

Australia

South Korea

Rest of Asia Pacific

Latin America

Brazil

Mexico

Rest of Latin America

Middle East and Africa

GCC

Africa

Rest of Middle East and Africa

Global Impact of COVID-19 Segment (2020-2021; US$ Million )

Pre COVID-19 situation

Post COVID-19 situation

Key questions answered in this report:

What are the key micro and macro environmental factors that are impacting the growth of Postpartum Hemorrhage (PPH) Treatment Devices market?

What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?

Estimated forecast and market projections up to 2031.

Which segment accounts for the fastest CAGR during the forecast period?

Which market segment holds a larger market share and why?

Are low and middle-income economies investing in the Postpartum Hemorrhage (PPH) Treatment Devices market?

Which is the largest regional market for Postpartum Hemorrhage (PPH) Treatment Devices market?

What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?

Which are the key trends driving Postpartum Hemorrhage (PPH) Treatment Devices market growth?

Who are the key competitors and what are their key strategies to enhance their market presence in the Postpartum Hemorrhage (PPH) Treatment Devices market worldwide?

Product Code: 138127-01-23

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Postpartum Hemorrhage (PPH) Treatment Devices Market
  • 2.2. Global Postpartum Hemorrhage (PPH) Treatment Devices Market, By Product, 2021 (US$ Million)
  • 2.3. Global Postpartum Hemorrhage (PPH) Treatment Devices Market, By Geography, 2021 (US$ Million)
  • 2.4. Attractive Investment Proposition by Geography, 2021

3. Postpartum Hemorrhage (PPH) Treatment Devices Market: Competitive Analysis

  • 3.1. Market Positioning of Key Postpartum Hemorrhage (PPH) Treatment Devices Market Vendors
  • 3.2. Strategies Adopted by Postpartum Hemorrhage (PPH) Treatment Devices Market Vendors
  • 3.3. Key Industry Strategies
  • 3.4. Tier Analysis 2021 Versus 2030

4. Postpartum Hemorrhage (PPH) Treatment Devices Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global Postpartum Hemorrhage (PPH) Treatment Devices Market Value, 2020 - 2030, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis

5. Postpartum Hemorrhage (PPH) Treatment Devices Market: By Product, 2020-2030, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2021 Versus 2030
  • 5.3. Market Segmentation
    • 5.3.1. Uterine balloon tamponade
      • 5.3.1.1. Bakri balloon tamponade
      • 5.3.1.2. Condom catheter
      • 5.3.1.3. Foley catheter
      • 5.3.1.4. BT-Cath balloon
    • 5.3.2. Uniject prefilled injection system
    • 5.3.3. Non-pneumatic anti-shock garment (NASG)

6. North America Postpartum Hemorrhage (PPH) Treatment Devices Market, 2020-2030, USD (Million)

  • 6.1. Market Overview
  • 6.2. Postpartum Hemorrhage (PPH) Treatment Devices Market: By Product, 2020-2030, USD (Million)
  • 6.3.Postpartum Hemorrhage (PPH) Treatment Devices Market: By Region, 2020-2030, USD (Million)
    • 6.3.1.North America
      • 6.3.1.1. U.S.
        • 6.3.1.1.1. Postpartum Hemorrhage (PPH) Treatment Devices Market: By Product, 2020-2030, USD (Million)
      • 6.3.1.2. Canada
        • 6.3.1.2.1. Postpartum Hemorrhage (PPH) Treatment Devices Market: By Product, 2020-2030, USD (Million)
      • 6.3.1.3. Rest of North America
        • 6.3.1.3.1. Postpartum Hemorrhage (PPH) Treatment Devices Market: By Product, 2020-2030, USD (Million)

7. UK and European Union Postpartum Hemorrhage (PPH) Treatment Devices Market, 2020-2030, USD (Million)

  • 7.1. Market Overview
  • 7.2. Postpartum Hemorrhage (PPH) Treatment Devices Market: By Product, 2020-2030, USD (Million)
  • 7.3.Postpartum Hemorrhage (PPH) Treatment Devices Market: By Region, 2020-2030, USD (Million)
    • 7.3.1.UK and European Union
      • 7.3.1.1. UK
        • 7.3.1.1.1. Postpartum Hemorrhage (PPH) Treatment Devices Market: By Product, 2020-2030, USD (Million)
      • 7.3.1.2. Germany
        • 7.3.1.2.1. Postpartum Hemorrhage (PPH) Treatment Devices Market: By Product, 2020-2030, USD (Million)
      • 7.3.1.3. Spain
        • 7.3.1.3.1. Postpartum Hemorrhage (PPH) Treatment Devices Market: By Product, 2020-2030, USD (Million)
      • 7.3.1.4. Italy
        • 7.3.1.4.1. Postpartum Hemorrhage (PPH) Treatment Devices Market: By Product, 2020-2030, USD (Million)
      • 7.3.1.5. France
        • 7.3.1.5.1. Postpartum Hemorrhage (PPH) Treatment Devices Market: By Product, 2020-2030, USD (Million)
      • 7.3.1.6. Rest of Europe
        • 7.3.1.6.1. Postpartum Hemorrhage (PPH) Treatment Devices Market: By Product, 2020-2030, USD (Million)

8. Asia Pacific Postpartum Hemorrhage (PPH) Treatment Devices Market, 2020-2030, USD (Million)

  • 8.1. Market Overview
  • 8.2. Postpartum Hemorrhage (PPH) Treatment Devices Market: By Product, 2020-2030, USD (Million)
  • 8.3.Postpartum Hemorrhage (PPH) Treatment Devices Market: By Region, 2020-2030, USD (Million)
    • 8.3.1.Asia Pacific
      • 8.3.1.1. China
        • 8.3.1.1.1. Postpartum Hemorrhage (PPH) Treatment Devices Market: By Product, 2020-2030, USD (Million)
      • 8.3.1.2. Japan
        • 8.3.1.2.1. Postpartum Hemorrhage (PPH) Treatment Devices Market: By Product, 2020-2030, USD (Million)
      • 8.3.1.3. India
        • 8.3.1.3.1. Postpartum Hemorrhage (PPH) Treatment Devices Market: By Product, 2020-2030, USD (Million)
      • 8.3.1.4. Australia
        • 8.3.1.4.1. Postpartum Hemorrhage (PPH) Treatment Devices Market: By Product, 2020-2030, USD (Million)
      • 8.3.1.5. South Korea
        • 8.3.1.5.1. Postpartum Hemorrhage (PPH) Treatment Devices Market: By Product, 2020-2030, USD (Million)
      • 8.3.1.6. Rest of Asia Pacific
        • 8.3.1.6.1. Postpartum Hemorrhage (PPH) Treatment Devices Market: By Product, 2020-2030, USD (Million)

9. Latin America Postpartum Hemorrhage (PPH) Treatment Devices Market, 2020-2030, USD (Million)

  • 9.1. Market Overview
  • 9.2. Postpartum Hemorrhage (PPH) Treatment Devices Market: By Product, 2020-2030, USD (Million)
  • 9.3.Postpartum Hemorrhage (PPH) Treatment Devices Market: By Region, 2020-2030, USD (Million)
    • 9.3.1.Latin America
      • 9.3.1.1. Brazil
        • 9.3.1.1.1. Postpartum Hemorrhage (PPH) Treatment Devices Market: By Product, 2020-2030, USD (Million)
      • 9.3.1.2. Mexico
        • 9.3.1.2.1. Postpartum Hemorrhage (PPH) Treatment Devices Market: By Product, 2020-2030, USD (Million)
      • 9.3.1.3. Rest of Latin America
        • 9.3.1.3.1. Postpartum Hemorrhage (PPH) Treatment Devices Market: By Product, 2020-2030, USD (Million)

10. Middle East and Africa Postpartum Hemorrhage (PPH) Treatment Devices Market, 2020-2030, USD (Million)

  • 10.1. Market Overview
  • 10.2. Postpartum Hemorrhage (PPH) Treatment Devices Market: By Product, 2020-2030, USD (Million)
  • 10.3.Postpartum Hemorrhage (PPH) Treatment Devices Market: By Region, 2020-2030, USD (Million)
    • 10.3.1.Middle East and Africa
      • 10.3.1.1. GCC
        • 10.3.1.1.1. Postpartum Hemorrhage (PPH) Treatment Devices Market: By Product, 2020-2030, USD (Million)
      • 10.3.1.2. Africa
        • 10.3.1.2.1. Postpartum Hemorrhage (PPH) Treatment Devices Market: By Product, 2020-2030, USD (Million)
      • 10.3.1.3. Rest of Middle East and Africa
        • 10.3.1.3.1. Postpartum Hemorrhage (PPH) Treatment Devices Market: By Product, 2020-2030, USD (Million)

11. Company Profile

  • 11.1. C. R. Bard, Inc.
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Portfolio
    • 11.1.4. Strategic Initiatives
  • 11.2. Cook Medical, Inc.,
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Portfolio
    • 11.2.4. Strategic Initiatives
  • 11.3. Becton Dickinson and Company
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Portfolio
    • 11.3.4. Strategic Initiatives
  • 11.4. Teleflex Incorporated
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Portfolio
    • 11.4.4. Strategic Initiatives
  • 11.5. Bactiguard AB
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Portfolio
    • 11.5.4. Strategic Initiatives
  • 11.6. Utah Medical Products Inc.
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Portfolio
    • 11.6.4. Strategic Initiatives
  • 11.7. rd Stone Design
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Portfolio
    • 11.7.4. Strategic Initiatives
  • 11.8. Bactiguard AB
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Portfolio
    • 11.8.4. Strategic Initiatives
  • 11.9. Becton
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Portfolio
    • 11.9.4. Strategic Initiatives
  • 11.10. Dickinson and Company
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Portfolio
    • 11.10.4. Strategic Initiatives
  • 11.11. Clinical Innovations, LLC.
    • 11.11.1. Company Overview
    • 11.11.2. Financial Performance
    • 11.11.3. Product Portfolio
    • 11.11.4. Strategic Initiatives
  • 11.12. Cook
    • 11.12.1. Company Overview
    • 11.12.2. Financial Performance
    • 11.12.3. Product Portfolio
    • 11.12.4. Strategic Initiatives
  • 11.13. Obstetrx
    • 11.13.1. Company Overview
    • 11.13.2. Financial Performance
    • 11.13.3. Product Portfolio
    • 11.13.4. Strategic Initiatives
  • 11.14. Organon
    • 11.14.1. Company Overview
    • 11.14.2. Financial Performance
    • 11.14.3. Product Portfolio
    • 11.14.4. Strategic Initiatives
  • 11.15. Path
    • 11.15.1. Company Overview
    • 11.15.2. Financial Performance
    • 11.15.3. Product Portfolio
    • 11.15.4. Strategic Initiatives
  • 11.16. Teleflex Incorporated
    • 11.16.1. Company Overview
    • 11.16.2. Financial Performance
    • 11.16.3. Product Portfolio
    • 11.16.4. Strategic Initiatives
  • 11.17. Utah Medical Products, Inc
    • 11.17.1. Company Overview
    • 11.17.2. Financial Performance
    • 11.17.3. Product Portfolio
    • 11.17.4. Strategic Initiatives
  • 11.18. Others
    • 11.18.1. Company Overview
    • 11.18.2. Financial Performance
    • 11.18.3. Product Portfolio
    • 11.18.4. Strategic Initiatives
Product Code: 138127-01-23

List of Tables

  • TABLE 1 Global Postpartum Hemorrhage (PPH) Treatment Devices Market By Product, 2020-2030, USD (Million)
  • TABLE 2 Global Postpartum Hemorrhage (PPH) Treatment Devices Market By Uterine balloon tamponade, 2020-2030, USD (Million)
  • TABLE 3 North America Postpartum Hemorrhage (PPH) Treatment Devices Market By Product, 2020-2030, USD (Million)
  • TABLE 4 North America Postpartum Hemorrhage (PPH) Treatment Devices Market By Uterine balloon tamponade, 2020-2030, USD (Million)
  • TABLE 5 U.S. Postpartum Hemorrhage (PPH) Treatment Devices Market By Product, 2020-2030, USD (Million)
  • TABLE 6 U.S. Postpartum Hemorrhage (PPH) Treatment Devices Market By Uterine balloon tamponade, 2020-2030, USD (Million)
  • TABLE 7 Canada Postpartum Hemorrhage (PPH) Treatment Devices Market By Product, 2020-2030, USD (Million)
  • TABLE 8 Canada Postpartum Hemorrhage (PPH) Treatment Devices Market By Uterine balloon tamponade, 2020-2030, USD (Million)
  • TABLE 9 Rest of North America Postpartum Hemorrhage (PPH) Treatment Devices Market By Product, 2020-2030, USD (Million)
  • TABLE 10 Rest of North America Postpartum Hemorrhage (PPH) Treatment Devices Market By Uterine balloon tamponade, 2020-2030, USD (Million)
  • TABLE 11 UK and European Union Postpartum Hemorrhage (PPH) Treatment Devices Market By Product, 2020-2030, USD (Million)
  • TABLE 12 UK and European Union Postpartum Hemorrhage (PPH) Treatment Devices Market By Uterine balloon tamponade, 2020-2030, USD (Million)
  • TABLE 13 UK Postpartum Hemorrhage (PPH) Treatment Devices Market By Product, 2020-2030, USD (Million)
  • TABLE 14 UK Postpartum Hemorrhage (PPH) Treatment Devices Market By Uterine balloon tamponade, 2020-2030, USD (Million)
  • TABLE 15 Germany Postpartum Hemorrhage (PPH) Treatment Devices Market By Product, 2020-2030, USD (Million)
  • TABLE 16 Germany Postpartum Hemorrhage (PPH) Treatment Devices Market By Uterine balloon tamponade, 2020-2030, USD (Million)
  • TABLE 17 Spain Postpartum Hemorrhage (PPH) Treatment Devices Market By Product, 2020-2030, USD (Million)
  • TABLE 18 Spain Postpartum Hemorrhage (PPH) Treatment Devices Market By Uterine balloon tamponade, 2020-2030, USD (Million)
  • TABLE 19 Italy Postpartum Hemorrhage (PPH) Treatment Devices Market By Product, 2020-2030, USD (Million)
  • TABLE 20 Italy Postpartum Hemorrhage (PPH) Treatment Devices Market By Uterine balloon tamponade, 2020-2030, USD (Million)
  • TABLE 21 France Postpartum Hemorrhage (PPH) Treatment Devices Market By Product, 2020-2030, USD (Million)
  • TABLE 22 France Postpartum Hemorrhage (PPH) Treatment Devices Market By Uterine balloon tamponade, 2020-2030, USD (Million)
  • TABLE 23 Rest of Europe Postpartum Hemorrhage (PPH) Treatment Devices Market By Product, 2020-2030, USD (Million)
  • TABLE 24 Rest of Europe Postpartum Hemorrhage (PPH) Treatment Devices Market By Uterine balloon tamponade, 2020-2030, USD (Million)
  • TABLE 25 Asia Postpartum Hemorrhage (PPH) Treatment Devices Market By Product, 2020-2030, USD (Million)
  • TABLE 26 Asia Postpartum Hemorrhage (PPH) Treatment Devices Market By Uterine balloon tamponade, 2020-2030, USD (Million)
  • TABLE 27 China Postpartum Hemorrhage (PPH) Treatment Devices Market By Product, 2020-2030, USD (Million)
  • TABLE 28 China Postpartum Hemorrhage (PPH) Treatment Devices Market By Uterine balloon tamponade, 2020-2030, USD (Million)
  • TABLE 29 Japan Postpartum Hemorrhage (PPH) Treatment Devices Market By Product, 2020-2030, USD (Million)
  • TABLE 30 Japan Postpartum Hemorrhage (PPH) Treatment Devices Market By Uterine balloon tamponade, 2020-2030, USD (Million)
  • TABLE 31 India Postpartum Hemorrhage (PPH) Treatment Devices Market By Product, 2020-2030, USD (Million)
  • TABLE 32 India Postpartum Hemorrhage (PPH) Treatment Devices Market By Uterine balloon tamponade, 2020-2030, USD (Million)
  • TABLE 33 Australia Postpartum Hemorrhage (PPH) Treatment Devices Market By Product, 2020-2030, USD (Million)
  • TABLE 34 Australia Postpartum Hemorrhage (PPH) Treatment Devices Market By Uterine balloon tamponade, 2020-2030, USD (Million)
  • TABLE 35 South Korea Postpartum Hemorrhage (PPH) Treatment Devices Market By Product, 2020-2030, USD (Million)
  • TABLE 36 South Korea Postpartum Hemorrhage (PPH) Treatment Devices Market By Uterine balloon tamponade, 2020-2030, USD (Million)
  • TABLE 37 Latin America Postpartum Hemorrhage (PPH) Treatment Devices Market By Product, 2020-2030, USD (Million)
  • TABLE 38 Latin America Postpartum Hemorrhage (PPH) Treatment Devices Market By Uterine balloon tamponade, 2020-2030, USD (Million)
  • TABLE 39 Brazil Postpartum Hemorrhage (PPH) Treatment Devices Market By Product, 2020-2030, USD (Million)
  • TABLE 40 Brazil Postpartum Hemorrhage (PPH) Treatment Devices Market By Uterine balloon tamponade, 2020-2030, USD (Million)
  • TABLE 41 Mexico Postpartum Hemorrhage (PPH) Treatment Devices Market By Product, 2020-2030, USD (Million)
  • TABLE 42 Mexico Postpartum Hemorrhage (PPH) Treatment Devices Market By Uterine balloon tamponade, 2020-2030, USD (Million)
  • TABLE 43 Rest of Latin America Postpartum Hemorrhage (PPH) Treatment Devices Market By Product, 2020-2030, USD (Million)
  • TABLE 44 Rest of Latin America Postpartum Hemorrhage (PPH) Treatment Devices Market By Uterine balloon tamponade, 2020-2030, USD (Million)
  • TABLE 45 Middle East and Africa Postpartum Hemorrhage (PPH) Treatment Devices Market By Product, 2020-2030, USD (Million)
  • TABLE 46 Middle East and Africa Postpartum Hemorrhage (PPH) Treatment Devices Market By Uterine balloon tamponade, 2020-2030, USD (Million)
  • TABLE 47 GCC Postpartum Hemorrhage (PPH) Treatment Devices Market By Product, 2020-2030, USD (Million)
  • TABLE 48 GCC Postpartum Hemorrhage (PPH) Treatment Devices Market By Uterine balloon tamponade, 2020-2030, USD (Million)
  • TABLE 49 Africa Postpartum Hemorrhage (PPH) Treatment Devices Market By Product, 2020-2030, USD (Million)
  • TABLE 50 Africa Postpartum Hemorrhage (PPH) Treatment Devices Market By Uterine balloon tamponade, 2020-2030, USD (Million)
  • TABLE 51 Rest of Middle East and Africa Postpartum Hemorrhage (PPH) Treatment Devices Market By Product, 2020-2030, USD (Million)
  • TABLE 52 Rest of Middle East and Africa Postpartum Hemorrhage (PPH) Treatment Devices Market By Uterine balloon tamponade, 2020-2030, USD (Million)

List of Figures

  • FIG. 1 Global Postpartum Hemorrhage (PPH) Treatment Devices Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global Postpartum Hemorrhage (PPH) Treatment Devices Market: Quality Assurance
  • FIG. 5 Global Postpartum Hemorrhage (PPH) Treatment Devices Market, By Product, 2021
  • FIG. 6 Global Postpartum Hemorrhage (PPH) Treatment Devices Market, By Geography, 2021
  • FIG. 7 Market Geographical Opportunity Matrix - Global Postpartum Hemorrhage (PPH) Treatment Devices Market, 2021
  • FIG. 8 Market Positioning of Key Postpartum Hemorrhage (PPH) Treatment Devices Market Players, 2021
  • FIG. 9 Global Postpartum Hemorrhage (PPH) Treatment Devices Market - Tier Analysis - Percentage of Revenues by Tier Level, 2021 Versus 2030
  • FIG. 10 Global Postpartum Hemorrhage (PPH) Treatment Devices Market, By Product, 2021 Vs 2030, %
  • FIG. 11 U.S. Postpartum Hemorrhage (PPH) Treatment Devices Market (US$ Million), 2020 - 2030
  • FIG. 12 Canada Postpartum Hemorrhage (PPH) Treatment Devices Market (US$ Million), 2020 - 2030
  • FIG. 13 Rest of North America Postpartum Hemorrhage (PPH) Treatment Devices Market (US$ Million), 2020 - 2030
  • FIG. 14 UK Postpartum Hemorrhage (PPH) Treatment Devices Market (US$ Million), 2020 - 2030
  • FIG. 15 Germany Postpartum Hemorrhage (PPH) Treatment Devices Market (US$ Million), 2020 - 2030
  • FIG. 16 Spain Postpartum Hemorrhage (PPH) Treatment Devices Market (US$ Million), 2020 - 2030
  • FIG. 17 Italy Postpartum Hemorrhage (PPH) Treatment Devices Market (US$ Million), 2020 - 2030
  • FIG. 18 France Postpartum Hemorrhage (PPH) Treatment Devices Market (US$ Million), 2020 - 2030
  • FIG. 19 Rest of Europe Postpartum Hemorrhage (PPH) Treatment Devices Market (US$ Million), 2020 - 2030
  • FIG. 20 China Postpartum Hemorrhage (PPH) Treatment Devices Market (US$ Million), 2020 - 2030
  • FIG. 21 Japan Postpartum Hemorrhage (PPH) Treatment Devices Market (US$ Million), 2020 - 2030
  • FIG. 22 India Postpartum Hemorrhage (PPH) Treatment Devices Market (US$ Million), 2020 - 2030
  • FIG. 23 Australia Postpartum Hemorrhage (PPH) Treatment Devices Market (US$ Million), 2020 - 2030
  • FIG. 24 South Korea Postpartum Hemorrhage (PPH) Treatment Devices Market (US$ Million), 2020 - 2030
  • FIG. 25 Rest of Asia Postpartum Hemorrhage (PPH) Treatment Devices Market (US$ Million), 2020 - 2030
  • FIG. 26 Brazil Postpartum Hemorrhage (PPH) Treatment Devices Market (US$ Million), 2020 - 2030
  • FIG. 27 Mexico Postpartum Hemorrhage (PPH) Treatment Devices Market (US$ Million), 2020 - 2030
  • FIG. 28 Rest of Latin America Postpartum Hemorrhage (PPH) Treatment Devices Market (US$ Million), 2020 - 2030
  • FIG. 29 GCC Postpartum Hemorrhage (PPH) Treatment Devices Market (US$ Million), 2020 - 2030
  • FIG. 30 Africa Postpartum Hemorrhage (PPH) Treatment Devices Market (US$ Million), 2020 - 2030
  • FIG. 31 Rest of Middle East and Africa Postpartum Hemorrhage (PPH) Treatment Devices Market (US$ Million), 2020 - 2030
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!